BioCorRx (BICX) Equity Ratio (2010 - 2026)

BioCorRx has disclosed Equity Ratio across 17 years of filings, most recently posting 5.0 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 5.0, down 188.12% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.0 (down 188.12% YoY), and the FY2025 annual result was 5.23, up 83.67% from the prior year.
• Equity Ratio came in at 5.0 for Q1 2026 at BioCorRx, up from 5.23 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.14 in Q3 2025 to a low of 34.24 in Q1 2024.
• The 5-year median for Equity Ratio is 11.1 (2023), against an average of 13.79.
• Across the five-year window, Equity Ratio slumped 375.24% in 2022 and soared 100.77% in 2025, its largest moves.
• BioCorRx's Equity Ratio stood at 10.7 in 2022, then sank by 139.2% to 25.59 in 2023, then dropped by 25.09% to 32.01 in 2024, then soared by 83.67% to 5.23 in 2025, then climbed by 4.35% to 5.0 in 2026.
• The last three Equity Ratio figures came in at 5.0 (Q1 2026), 5.23 (Q4 2025), and 0.14 (Q3 2025), per Business Quant data.